Search

Alec Machiels Phones & Addresses

  • Pinecrest, FL
  • 131 E 94Th St, New York, NY 10128
  • 923 5Th St, New York, NY 10021 (212) 337-9963
  • 250 Mercer St, New York, NY 10012 (212) 337-9963
  • 11 Bank St, New York, NY 10014
  • 67 Jane St, New York, NY 10014
  • 44 Main St, Sharon, CT 06069 (860) 397-5152
  • 24 Baycrest Ave, Westhampton, NY 11977 (631) 288-0860
  • Cambridge, MA

Work

Company: Colift Sep 2019 Position: Founding managing partner

Education

Degree: Master of Business Administration, Masters School / High School: Harvard Business School 1999 to 2001 Specialities: Business Administration, Management, Business Administration and Management

Skills

Private Equity • Mergers and Acquisitions • Due Diligence • Corporate Finance • Investments • Business Strategy • Management • Strategic Planning • Valuation • Energy • Renewable Energy • Commodities • Healthcare • Marketing • Financial Institutions • Healthcare It • Biotechnology • Financial Modeling

Languages

French • Dutch • German • Spanish • English

Industries

Investment Management

Resumes

Resumes

Alec Machiels Photo 1

Founding Managing Partner

View page
Location:
250 Mercer St, New York, NY 10012
Industry:
Investment Management
Work:
Colift
Founding Managing Partner

Revon Systems Nov 2013 - Aug 2019
Co-Founder, Board Member

Pegasus Capital Advisors Jul 2002 - Jun 2019
Alec Machiels Partner

American Federation of Arts Jan 2010 - Dec 2013
Trustee

Apellis Pharmaceuticals Jan 2010 - Dec 2013
Co-Founder, Director
Education:
Harvard Business School 1999 - 2001
Master of Business Administration, Masters, Business Administration, Management, Business Administration and Management
University of Konstanz 1995 - 1996
Ku Leuven Faculty of Engineering Technology & Faculty of Movement and Rehabilitation Sciences 1992 - 1995
Masters, Master of Laws, Law
Université Saint - Louis - Bruxelles 1990 - 1992
Bachelors, Bachelor of Law, Law
Skills:
Private Equity
Mergers and Acquisitions
Due Diligence
Corporate Finance
Investments
Business Strategy
Management
Strategic Planning
Valuation
Energy
Renewable Energy
Commodities
Healthcare
Marketing
Financial Institutions
Healthcare It
Biotechnology
Financial Modeling
Languages:
French
Dutch
German
Spanish
English

Publications

Us Patents

Compositions And Methods For Enhancing Phagocytosis Or Phagocyte Activity

View page
US Patent:
20050113297, May 26, 2005
Filed:
Aug 23, 2004
Appl. No.:
10/923940
Inventors:
Cedric Francois - Louisville KY, US
Pascal Deschatelets - Louisville KY, US
Paul Olson - Louisville KY, US
Alec Machiels - New York NY, US
International Classification:
A61K038/17
C12N005/08
US Classification:
514012000, 435372000
Abstract:
The present invention provides a system for enhancing clearance or destruction of undesirable cells or noncellular molecular entities by tagging such cells or noncellular molecular entities with a marker that targets the cells or noncellular molecular entities for phagocytosis (phagocytic marker). The target cells can be, for example, endothelial cells, tumor cells, leukocytes, or virus-infected cells. In certain embodiments of the invention the tagging is accomplished by administering a composition comprising an antibody or ligand linked to the phagcytotic marker, wherein the antibody or ligand binds to a cell type specific marker present on or in the cell surface of a target cell. In preferred embodiments of the invention, the phagocytic marker comprises phosphatidylserine or a group derived from phosphatidylserine, thrombospondin-1, annexin I, or a derivative of any of these.

Schedule-Based Electronic Medical Record Modules, Applications, And Uses Thereof

View page
US Patent:
20160147951, May 26, 2016
Filed:
Nov 19, 2015
Appl. No.:
14/945991
Inventors:
- Crestwood KY, US
Gaurav Bazaz - Edgewater NJ, US
Alec Machiels - New York NY, US
Pascal Deschatelets - Prospect KY, US
Monica Gerber - Somerville MA, US
International Classification:
G06F 19/00
Abstract:
In some aspects, the present disclosure provides a computer program product for assembling a database comprising electronic data modules, which may be electronic medical records (EMRs). The present disclosure can also be used for purposes such as implementing a system in which physicians and patents can be provided with applications that they can use to confirm that various disease related events have taken place. This can be performed using active diagnosis modules (ADMs) comprising schedules of events. These ADMs and their events can also be used to populate a database which can be used for purposes such as identifying, recruiting and tracking participants in clinical trials.
Alec I Machiels from Pinecrest, FL, age ~52 Get Report